The logo – which retains the company’s traditional blue colour scheme – has been more than 18 months in the making and according to the company it is “unlocking the pill to reveal Pfizer ...

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the ...

Holmes said she put Pfizer and Schering-Plough's logos on validation reports before sharing them with Walgreens because "this work was done in partnership with those companies and I was trying to ...

Its logo still adorns some walls, and scientists from Seagen and Pfizer are writing papers together. “They have the secret ...

Jefferies analyst Akash Tewari maintained a Buy rating on Pfizer (PFE – Research Report) today and set a price target of $33.00. The company’s shares closed yesterday at $26.24. Tewari covers the ...

Pfizer (PFE) offered up some more details on its weight loss drug pipeline on Tuesday during a call with investors after it ...

Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in ...

More than a few companies that did well in the past are out of favor with investors. And that could spell opportunity.

In life, there’s a common expression that also carries over into the dividend investing world: If it seems too good to be true, it usually is ...

FILE - The Pfizer logo is displayed at the company's headquarters, Friday, Feb. 5, 2021, in New York. A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third ...

A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year. Demand for the drugmaker’s Paxlovid treatment spurred by the ...